Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
1.770
-0.060 (-3.28%)
At close: Feb 21, 2025, 4:00 PM
1.800
+0.030 (1.69%)
After-hours: Feb 21, 2025, 7:32 PM EST
Sutro Biopharma Employees
Sutro Biopharma had 302 employees as of December 31, 2023. The number of employees increased by 24 or 8.63% compared to the previous year.
Employees
302
Change (1Y)
24
Growth (1Y)
8.63%
Revenue / Employee
$532,964
Profits / Employee
-$410,440
Market Cap
145.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
STRO News
- 6 weeks ago - Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Sutro Biopharma: I Don't Buy That Their Pipeline Is Worthless - Seeking Alpha
- 3 months ago - Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 3 months ago - Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference - GlobeNewsWire
- 4 months ago - Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML - GlobeNewsWire
- 4 months ago - Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum - GlobeNewsWire
- 5 months ago - Sutro Biopharma's Competitive ADCs Position It For Future Growth In Oncology - Seeking Alpha
- 5 months ago - Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire